chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 23.0
Sex: F
Vaccine: FLUX
Symptoms: Urticaria
Clinical narrative: This spontaneous case, reported by other non-healthcare professional (consumer) to VAERS and initially retrieved on 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 730224), concerns a 23-year-old, adult, female patient. The patient's historical vaccines included influenza vaccine in 2011 (at age 17), in 2012 (at age 18), and in 2013 at (age 19) which caused severe muscle aches, lasted more than three days. The patient's current conditions included endometriosis and ADHD (attention deficit hyperactivity disorder) (since an unspecified date). The patient's concomitant medication included dextroamphetamine. On 30-Nov-2017, the patient was administered with influenza vaccine (dose: reported as 1, route of administration: intramuscular, anatomical location: right arm, batch number, expiry date, manufacturer and trade name: not reported). On 03-Dec-2017, after 3 days of vaccination, the patient woke up with welt approximately size of a nickel on the back of left thigh and an area that was covered with clothing, which was believed as it was a spider bite. The patient applied some hydrocortisone cream and went back to sleep. On 04-Dec-2017, in night, the patient woke up with more severe welts and hives. The size of a welt was of half dollar on her coccyx, 6-7 smaller ones (about the size of a pencil eraser) covering her left and right butt cheek, four approximately half dollar sized welts down to her left thigh. Additionally, there was circular patch of hives approximately three inches in diameter on her left butt cheek. All areas were covered with clothing while she slept. On 05-Dec-2017 (reported as Tuesday night), the reaction got worsened and the patient woke up with patches of welts covering her arms, engulfing her lower legs and size of her smallest finger on her abdomen and upper back. The patient received BENADRYL and her symptoms were subsided. On an unspecified date, the patient had recovered from the event. The reporter assessed the events as non-serious. This case 201802205 was cross linked to case 201802207 reported by same reporter.
Age: 4.0
Sex: M
Vaccine: FLUX, IPV, MMRV
Symptoms: Pyrexia
Clinical narrative: This is non-serious spontaneous case, reported by healthcare professional to VAERS and initially retrieved on 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 730390), concerns a 4-year-old, male child patient. The patient's medical history and concomitant medications were not reported. On 04-Dec-2017, the patient received INN Flu Vaccine Seasonal (dose: reported as unk, anatomical location: arm, batch number, trade name, manufacturer: not reported). On the same day, the patient also received non-company suspect PROQUAD (dose: reported as unk, anatomical location: left arm, batch number, trade name, manufacturer: not reported) and IPOL (dose: reported as unk, anatomical location: arm, batch number, trade name, manufacturer: not reported). On 07-Dec-2017, 3 days after vaccination, the patient experienced fever of 102.9 for 3 days which was not linked to illness. It was reported that, the patient had an office visit. At the time of report, the patient recovered from the event (pyrexia).
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Limb discomfort, Muscular weakness
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 17-Jul-2018 by Seqirus from VAERS (VAERS ID: 730591), concerns a 64-year-old, adult female patient. The patient's historical condition included chronic obstructive pulmonary disease (COPD). The patient had no current illness, allergies and was unsure of the concomitant medications. On 28-Nov-2017, the patient was administered FLUVIRIN (dose: 0.5 ml, frequency: 1, route of administration: intramuscular, anatomical location: left arm, batch number: 179905P and expiry date: not reported). On the same day after vaccination, the patient experienced weakness and heaviness in arm. At the time of this report, the patient had not recovered from the events. The reporter assessed this case as non-serious.
Age: 52.0
Sex: F
Vaccine: FLUX
Symptoms: Pruritus, Rash
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 730714), concerns a 52-year-old, adult, female patient. The patient's current condition included HTN (hypertension) and asthma (since an unspecified date). On 08-Dec-2017, the patient was administered with influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, manufacturer and trade name: not reported). On the same day, after vaccination, the patient developed rash and pruritus in night. The patient went to the emergency room. On an unspecified date, the patient had recovered from the events. The reporter assessed the events as non-serious.
Age: 1.5
Sex: M
Vaccine: FLUX, MMR, VARCEL
Symptoms: Urticaria
Clinical narrative: This spontaneous case, reported by other health professional (nurse) to VAERS and initially retrieved on 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 730899), concerning an 18-month-old, male infant patient (age reported as 1.50). The patient's medical history and concomitant medications were not reported. On an unspecified date (reported as before 06-Nov-2017), the patient was administered with influenza vaccine, (dose, route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported). The patient was also administered with non-company suspect drug MMR II and VARIVAX (dose, route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported). On the same day, two hours after vaccination, the patient experienced hives on an unspecified location on the body. It was unknown which vaccine caused the hives. The patient made a visit to the physician's office for the event. No treatment was received for the event and no lab test was performed. The patient saw pediatrician and went to allergist's office. On an unknown date, the patient had recovered from the event. The reporter assessed the case as non-serious.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Corneal reflex decreased, Facial paralysis, Facial spasm, Hypoaesthesia oral, Muscle twitching
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 17-Jul-2018 by Seqirus from VAERS (VAERS ID: 730935), concerns a 54-year-old, adult, female patient. The patient had no medical history. The patient's current condition included sinus and had unspecified allergies. On 30-Nov-2017, the patient was administered FLUVIRIN Thiomersal [dose: 0.5 ml, frequency reported as 5, route of administration: intramuscular, batch number: 1720801, anatomical location: unknown and expiry date: not reported]. On an unspecified date, after vaccination, the patient developed a delayed left eye blinking, twitching on the right side of mouth, arching of right eye brows. The patient's middle part of the tongue was numb. The magnetic resonance imaging [MRI] of brain was performed which showed possible Bell's palsy. At the time of this report, the patient had not recovered from the events (delayed blinking of left eye, twitching on right side of mouth, arching of right eye brows, middle of tongue is numb). The reporter assessed the case as non-serious. Update received on 19-Sep-2018: Significant case correction received with (IRD: 17-Jul-2018): The event (MRI brain) was deleted. The sentences 'the patient had no medical history' and 'the magnetic resonance imaging [MRI] of brain was performed which showed possible Bell's palsy' were added in the narrative.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Nuclear magnetic resonance imaging brain abnormal
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 17-Jul-2018 by Seqirus from VAERS (VAERS ID: 730935), concerns a 54-year-old, adult, female patient. The patient had no medical history. The patient's current condition included sinus and had unspecified allergies. On 30-Nov-2017, the patient was administered FLUVIRIN Thiomersal [dose: 0.5 ml, frequency reported as 5, route of administration: intramuscular, batch number: 1720801, anatomical location: unknown and expiry date: not reported]. On an unspecified date, after vaccination, the patient developed a delayed left eye blinking, twitching on the right side of mouth, arching of right eye brows. The patient's middle part of the tongue was numb. The magnetic resonance imaging [MRI] of brain was performed which showed possible Bell's palsy. At the time of this report, the patient had not recovered from the events (delayed blinking of left eye, twitching on right side of mouth, arching of right eye brows, middle of tongue is numb). The reporter assessed the case as non-serious. Update received on 19-Sep-2018: Significant case correction received with (IRD: 17-Jul-2018): The event (MRI brain) was deleted. The sentences 'the patient had no medical history' and 'the magnetic resonance imaging [MRI] of brain was performed which showed possible Bell's palsy' were added in the narrative.
Age: 60.0
Sex: F
Vaccine: FLUX
Symptoms: Nausea, Vomiting
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 731104), concerns a 60-year-old, adult, female patient. The patient historical vaccine included influenza vaccine and had not experienced any reaction. On 27-Sep-2017, the patient was administered with influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, manufacturer and trade name: not reported). On the same day, after vaccination, the patient experienced nausea and vomiting. At the time of this report, the outcome of events was unknown. The reporter assessed these events as non-serious.
Age: 72.0
Sex: M
Vaccine: FLUX
Symptoms: Rash
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 731201), concerns a 72-year-old, elderly, male patient. On 07-Oct-2017, the patient was administered with influenza vaccine, (dose, route of administration, anatomical location, batch number, expiry date, manufacturer and trade name: not reported). On the same day, after vaccination, the patient experienced rash. On an unspecified date, the patient had recovered from the event. The reporter assessed the events as non-serious.
Age: 42.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Fatigue, Feeling abnormal, Injection site swelling, Myalgia, Pain
Clinical narrative: This is spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 17-Jul-2018 by Seqirus from VAERS (VAERS ID: 731264), concerns a 42-year-old, adult, female patient. The patient's current conditions sleep apnoea, diabetes, high blood pressure, high cholesterol and allergic to penicillin, sulphonamide (reported as sulpha) (reported as medical history). The patient's concomitant medications included DIOVAN, CELEXA; Vitamin D; LANTUS, Glimepiride for unknown indications. On 13-Dec-2017, the patient was administered FLUVIRIN (dose: 0.5ml, frequency: 1, route of administration: injection [SYR as reported], anatomical location: right arm, batch number and expiry date: not reported). On the same day, the patient also received non-company suspect PREVNAR 13 (dose, route of administration, anatomical location, batch number and expiry date: not reported). On the same day, after vaccination in the night, the patient's arm was throbbing severely and could not sleep as it hurt so much. Additionally, the patient's injection site was swollen. The patient stated that after few days, pain was relieved. The patient felt her brain was foggy and did not feel all there (as reported). It was reported that, the patient felt exhausted and run down that she could not wake up. At the time of this report, the patient also had muscle pains (reported as all body muscle pain). The patient had all the symptoms since a week and felt the same at the time of this report. The outcome of the event- injection site swelling was unknown. The reporter assessed this case as non-serious. Update 14-Aug-2018: Significant case correction was performed with IRD 17-Jul-2018: The event 'pain' was added. The case comment was corrected from 'couldn't even sleep, arm was throbbing, very foggy brained/not feeling all there, very swollen and around the injection site, exhausted/cannot wake up, body muscle pain after vaccination with suspect "FLUVIRIN' and co-suspect 'PREVNAR 13'. The causality between the events and suspect vaccine is assessed as related based on the plausible temporal relationship' to 'insomnia, pain in extremity, myalgia, fatigue and feeling abnormal on the same day after the receipt of suspect vaccine FLUVIRIN. The causality of the events pain, pain in extremity, myalgia, fatigue and feeling abnormal are assessed as related due to plausible temporal relationship to suspect vaccine. However, the events insomnia is assessed as not related and causality for injection site swelling cannot be assessed due to lack of information regarding anatomical location involving the adverse event. Pneumococcal vaccine is considered as so-suspect vaccine'.
Age: 42.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Sleep disorder, Somnolence
Clinical narrative: This is spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 17-Jul-2018 by Seqirus from VAERS (VAERS ID: 731264), concerns a 42-year-old, adult, female patient. The patient's current conditions sleep apnoea, diabetes, high blood pressure, high cholesterol and allergic to penicillin, sulphonamide (reported as sulpha) (reported as medical history). The patient's concomitant medications included DIOVAN, CELEXA; Vitamin D; LANTUS, Glimepiride for unknown indications. On 13-Dec-2017, the patient was administered FLUVIRIN (dose: 0.5ml, frequency: 1, route of administration: injection [SYR as reported], anatomical location: right arm, batch number and expiry date: not reported). On the same day, the patient also received non-company suspect PREVNAR 13 (dose, route of administration, anatomical location, batch number and expiry date: not reported). On the same day, after vaccination in the night, the patient's arm was throbbing severely and could not sleep as it hurt so much. Additionally, the patient's injection site was swollen. The patient stated that after few days, pain was relieved. The patient felt her brain was foggy and did not feel all there (as reported). It was reported that, the patient felt exhausted and run down that she could not wake up. At the time of this report, the patient also had muscle pains (reported as all body muscle pain). The patient had all the symptoms since a week and felt the same at the time of this report. The outcome of the event- injection site swelling was unknown. The reporter assessed this case as non-serious. Update 14-Aug-2018: Significant case correction was performed with IRD 17-Jul-2018: The event 'pain' was added. The case comment was corrected from 'couldn't even sleep, arm was throbbing, very foggy brained/not feeling all there, very swollen and around the injection site, exhausted/cannot wake up, body muscle pain after vaccination with suspect "FLUVIRIN' and co-suspect 'PREVNAR 13'. The causality between the events and suspect vaccine is assessed as related based on the plausible temporal relationship' to 'insomnia, pain in extremity, myalgia, fatigue and feeling abnormal on the same day after the receipt of suspect vaccine FLUVIRIN. The causality of the events pain, pain in extremity, myalgia, fatigue and feeling abnormal are assessed as related due to plausible temporal relationship to suspect vaccine. However, the events insomnia is assessed as not related and causality for injection site swelling cannot be assessed due to lack of information regarding anatomical location involving the adverse event. Pneumococcal vaccine is considered as so-suspect vaccine'.
Sex: F
Vaccine: FLUX
Symptoms: Abdominal pain upper, Diarrhoea
Clinical narrative: This non-serious spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 17-Jul-2018 by Seqirus from VAERS (VAERS ID: 731767), concerns an adult female patient. The patient's historical conditions included: dry eyes, menstrual migraines, exercise induced migraine, steroid induced migraine and possible chronic fatigue. The patient's current conditions included: atopy, hay fever, atopic dermatitis, eczema, rosacea, seborrheic dermatitis, ocular rosacea, anxiety and depression (reported as medical history). The patient was allergic to corn, dust mite, mold, grasses, rag weed, trees, dairy, chocolate, nuts, ciprofloxacin, DURICEF, PATANOL, BESIVANCE, LODINE, CELEBREX, MOBIC, BIAXIN, AUGMENTIN and was allergic to numerous soaps (reported as medical history). Concomitant medications included: Vitamin C, BUSPAR and ATIVAN. On an unspecified date in 2016, the patient was administered influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported). On an unspecified date, after vaccination, the patient experienced stomach pain and diarrhea. At the time of this report, the outcome of the events was not reported. This case was linked to the case: 201803001 (same patient).
Age: 31.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 17-Jul-2018 by Seqirus from VAERS (VAERS ID: 731977), concerns a 31-year-old, adult male patient. The patient's concomitant medications were unknown. On 17-Nov-2017, the patient was administered FLUVIRIN Thiomersal (dose: 0.5ml [reported as 1st dose], route of administration: unknown, anatomical location: left arm, batch number: 1721501 and expiry date: not reported). On 18-Dec-2017, approximately at 03:00 pm, the patient reported that, he experienced a pain in shoulder area, where injection was given (on an unspecified date in 2017). The patient received ADVIL and TYLENOL, which relieved the pain and soreness. However, the event re-occurred frequently (reported as 'keeps coming back'). At the time of this report, the outcome of the event was unknown. The reporter assessed the case as non-serious.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Feeling abnormal, Hypoaesthesia
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 17-Jul-2018 by Seqirus from VAERS (VAERS ID: 732131), concerning a 33-year-old, adult, female patient. On 28-Dec-2017, the patient was administered FLUVIRIN (dose: 0.5 ml, frequency: 1, route of administration: intramuscular, anatomical location: left arm, batch number: 170104P and expiry date: not reported). On the same day (28-Dec-2017), after vaccination, the patient had numbness and weird feeling along the left side of body. The events resolved within 15 minutes [recovered] and the patient left the pharmacy. The reporter assessed the case as non-serious.
Age: 58.0
Sex: F
Vaccine: FLUX, VARZOS
Symptoms: Erythema, Pain, Pain in extremity, Peripheral swelling
Clinical narrative: This is spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 732302), concerns a 58-year-old, adult, female patient. The patient's current conditions included blood pressure and cholesterol abnormal. The patient was allergic to hydrocortisone. The patient's concomitant medication included simvastatin, unspecified blood pressure medications and unspecified cholesterol medications. On 11-Nov-2017, the patient was administered influenza vaccine (dose, batch number, route of administration, anatomical location, trade name, manufacturer was unknown). On the same day, the patient also received non-company suspect ZOSTAVAX (dose, batch number, route of administration and anatomical location: was unknown). On the same day (11-Nov-2017), the patient developed a big swollen arm appeared like ball and redness that persisted (reported as stay that way for 5 days) for 5 days. It was reported that, the arm hurt upon use. Complete information was not available as they doctor was at clinic. The patient had an office visit on an unspecified date and consulted the nurse at the clinic to examine the arm. The patient had recovered from all the events. The reporter assessed this case as non-serious. Update 22-Jul-2018: Case correction was performed 18-Jun-2018: The sentence in the case comment was corrected from 'a 58-year-old, adult female patient experienced erythema, pain, pain in extremity and peripheral swelling' to 'a 58-year-old, female patient experienced erythema, pain, pain in extremity and peripheral swelling on the same day after vaccination with the suspect vaccine (INN flu vaccine seasonal) and co-suspect vaccine (ZOSTAVAX)'.
Age: 58.0
Sex: F
Vaccine: FLUX
Symptoms: Pruritus
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 732720), concerns a 58-year-old, adult female patient. The patient's medical history and concomitant medications were not reported. On 08-Nov-2017, the patient was administered with influenza vaccine, (dose, batch number, route of administration, trade name, manufacturer was unknown). On the same day (08-Nov-2017), after vaccination, the patient experienced pruritus. On an unspecified date, the patient had recovered from pruritus. The reporter assessed the case as non-serious.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Mobility decreased, Musculoskeletal pain, Pain in extremity
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 25-Jul-2018 by Seqirus from VAERS (VAERS ID: 732730), concerning a 32-year-old, adult, female patient. On 25-Dec-2017, the patient was administered FLUVIRIN (TIV) (dose: 0.5 ml, batch number: 179901P, route of administration: unknown, anatomical location: right arm, expiry date: not reported). On the same day, after the vaccination the patient experienced arm pain. On 02-Jan-2-2018, 7 days after the vaccination, the patient had pain in shoulder and was unable to raise the arm above head. At the time of the report, the outcome of the events was unknown. The reporter assessed the case as non-serious. Update 24-Aug-2018: Significant case correction was performed with IRD 25-Jul-2018: As determined listedness of the event (unable to raise arm above head) was corrected from 'Listed' to 'Unlisted' in Pl Flu Vaccine Egg Subunit NVD in event assessment tab.
Age: 81.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Asthenia, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: This spontaneous case, reported by a pharmacist via a company representative to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 732759), concerns an 81-year-old, elderly female patient. The patient's medical history, current conditions and concomitant medications were not reported. On 27-Nov-2017, the patient was administered with influenza vaccine (anatomical location: arm (unknown whether were administered in the left arm or the right arm), high flu dose (as reported), route of administration, batch number, expiry date: not reported). On the same day, the patient was also administered with non-company suspect drug PNEUMOVAX (anatomical location: arm (unknown whether were administered in the left arm or the right arm), dose, route of administration, batch number, expiry date: not reported). On the same of vaccination, the patient felt weak, experienced ache (reported as achiness) as well as redness, pain and swelling at the injection site. The patient sought medical attention by visiting the physician and was given an unspecified treatment for the events. At the time of this report, the outcome of the events was unknown. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUX, PNC13
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 732781), concerns a female patient of unspecified age and age group. The patient's medical history and concomitant medications were not reported. It was reported that, the patient received a shot on an unspecified date. On 12-Oct-2017, the patient was administered with influenza vaccine (dose, route of administration, anatomical location, batch number and expiry date: not reported) and non-company suspect product PREVNAR 13 (dose, route of administration, anatomical location, batch number and expiry date: not reported). On an unspecified date in Oct-2017, after 4 days of vaccination, the patient experienced pain in the left leg. At the time this report, the outcome of the event (pain in leg) was unknown. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUX
Symptoms: Dizziness
Clinical narrative: This spontaneous case, reported by other non-healthcare professional (consumer) to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 733282), concerns a female patient of an unspecified age. The patient's historical conditions, current illness, allergies and concomitant medications were not reported. On an unspecified date (reported as 20 years ago), the patient was administered with influenza vaccine, (dose, route of administration, anatomical location, batch number, expiry date, manufacturer and trade name: not reported). On an unspecified date, after vaccination, the patient experienced dizziness. The patient's lab investigations and corrective treatment for the event was not reported. At the time of this report, the outcome of the event was unknown. The reporter assessed the case as non-serious.
Age: 27.0
Sex: M
Vaccine: FLU3, HPV9
Symptoms: Asthenia, Blood pressure increased, Chest pain, Dysacusis, Feeling abnormal
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 25-Jul-2018 by Seqirus from VAERS (VAERS ID: 733677), concerns a 27-year-old, adult male patient. The patient's medical history included human immunodeficiency virus (HIV) and Hepatitis C. The patient had taken unspecified treatment for Hepatitis C. The patient was allergic to peanuts and shrimps. On 12-Dec-2017, the patient was administered FLUVIRIN thiomersal (dose: 0.5 ml, frequency: 1, route of administration: intramuscular, anatomical location: left vastus lateralis, batch number: 1721301 and expiry date: not reported) which was tolerated well and GARDASIL 9 (frequency: 1, route of administration: intramuscular, anatomical location: right vastus lateralis, batch number: M007728, dose and expiry date: not reported). On the same day (12-Dec-2017), within 3-5 minutes after vaccination with GARDASIL, the patient experienced weird feeling and weakness. Later, the patient complained of burning sensation of throat and chest. These conditions progressed to numbness which had spread from head to toe. The patient stated that, he had been hearing the echoes of his voice, which was followed by twitching of right arm and foot. The patient was little sluggish but remained oriented (x 4 as reported). It was reported that the patient denied shortness of breath, chest pain and wheezing. The patient was taken to hospital by emergency service team. The patient's blood pressure was increased to 150s/90s, the peripheral capillary oxygen saturation (SPO2) was found to be 98 percent on room air and other vital signs were stable. It was reported that, attempt was made to contact the patient, but it was unsuccessful. The lab data was reported as none. At the time of this report, the outcome of the events was unknown. The reporter assessed the case as non-serious.
Age: 27.0
Sex: M
Vaccine: FLU3, HPV9
Symptoms: Hypoaesthesia, Muscle twitching, Sluggishness, Throat irritation
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 25-Jul-2018 by Seqirus from VAERS (VAERS ID: 733677), concerns a 27-year-old, adult male patient. The patient's medical history included human immunodeficiency virus (HIV) and Hepatitis C. The patient had taken unspecified treatment for Hepatitis C. The patient was allergic to peanuts and shrimps. On 12-Dec-2017, the patient was administered FLUVIRIN thiomersal (dose: 0.5 ml, frequency: 1, route of administration: intramuscular, anatomical location: left vastus lateralis, batch number: 1721301 and expiry date: not reported) which was tolerated well and GARDASIL 9 (frequency: 1, route of administration: intramuscular, anatomical location: right vastus lateralis, batch number: M007728, dose and expiry date: not reported). On the same day (12-Dec-2017), within 3-5 minutes after vaccination with GARDASIL, the patient experienced weird feeling and weakness. Later, the patient complained of burning sensation of throat and chest. These conditions progressed to numbness which had spread from head to toe. The patient stated that, he had been hearing the echoes of his voice, which was followed by twitching of right arm and foot. The patient was little sluggish but remained oriented (x 4 as reported). It was reported that the patient denied shortness of breath, chest pain and wheezing. The patient was taken to hospital by emergency service team. The patient's blood pressure was increased to 150s/90s, the peripheral capillary oxygen saturation (SPO2) was found to be 98 percent on room air and other vital signs were stable. It was reported that, attempt was made to contact the patient, but it was unsuccessful. The lab data was reported as none. At the time of this report, the outcome of the events was unknown. The reporter assessed the case as non-serious.
Sex: M
Vaccine: DTAPHEPBIP, FLUX, RV1
Symptoms: Cough, Respiratory tract congestion, Rhinorrhoea, Sneezing
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 18-June-2018 by Seqirus from VAERS (VAERS ID: 733794), concerns a 06-month-old, male infant. The patient's current condition included ear infection (since an unspecified date) and the patient had no allergies and concomitant medications. On 11-Jan-2018, the patient was administered influenza vaccine (dose: 1 [first dose as reported], route of administration: injection [reported by SYR], anatomical location: leg, batch number and expiry date: not reported), ROTARIX (route of administration: oral, anatomical location: mouth, dose, batch number and expiry date: not reported) and PEDIARIX (route of administration: injection [reported as SYR], anatomical location: leg, dose, batch number and expiry date: not reported). On 12-Jan-2018, 1 day after vaccination, the patient experienced runny nose, congestion, cough and sneezing. At the time of this report, the patient had not recovered from the events. The reporter assessed this case as non-serious. Update 22-Jul-2018: Non-significant case correction received with IRD 18-Jun-2018: The co-suspects (ROTARIX and PEDIARIX) were added in the case comment.
Sex: M
Vaccine: DTAPIPVHIB, FLUX, HEP, PPV
Symptoms: Injection site erythema, Irritability, Pyrexia, Vaccination site swelling, Vomiting
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 733797), concerns a 06-month-old infant male patient. The patient's historical vaccine included unspecified routine vaccines, which caused standard low fever. The patient's historical conditions included torticollis and plagiocephaly (unspecified date). The patient's current condition included influenza A (since 23-Dec-2017). The patient's concomitant medications were not reported. On 12-Jan-2018, the patient was administered with influenza vaccine (dose: 1 [as reported], route of administration: injection [reported as SYR], anatomical location: left gluteus, batch number, expiry date, manufacturer and trade name: not reported) and non-company suspect products PENTACEL (route of administration: injection [reported as SYR], anatomical location: left gluteus, batch number, expiry date and dose: not reported), Hepatitis B vaccine (route of administration: injection [reported as SYR], anatomical location: left gluteus, batch number, expiry date and dose: not reported) and Pneumococcal vaccine (route of administration: injection [reported as SYR], anatomical location: left gluteus, batch number, expiry date and dose: not reported). On 13-Jan-2018, one day after vaccination in early hours of morning, the patient experienced low-grade fever, vaccination site swelling and redness. The patient was treated with cold compress therapy but had no immediate improvement. Approximately after 24 hours of vaccination, the patient became unusually fussy and then forcefully (reported as 'not quite projectile') vomited an entire feeding. The reporter considered the events (vaccination site swelling and redness) as normal. It was reported that, the patient slept after the occurrence of the events. At the time of this report, the outcome of the events was unknown. The reporter assessed the case as non-serious.
Age: 31.0
Sex: U
Vaccine: FLU3
Symptoms: Injection site pain, Pain, Pain in extremity, Somnolence
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 25-Jul-2018 by Seqirus from VAERS (VAERS ID: 733800), concerns a 31-year-old, adult, female patient. The patient had no medical history, current illness and no known allergies. The patient had no concomitant medications. On 04-Jan-2018, the patient was administered FLUVIRIN (dose: 0.5 ml, frequent: 1, route of administration: injection [reported as SYR], anatomical location: left arm, batch number and expiry date: not reported). It was reported that the patient stated that she don't know the specific vaccine, but it was the flu vaccine for the 2017/2018 flu season. On the same day (04-Jan-2018), after vaccination, the patient experienced standard ache and drowsiness for 2 days. One week and 2 days later, the patient's arm pain had changed and worsened. The patient had on and off muscle pain at the site of the injection. The patient could move her arm without any issue but could not identify the trigger for the pain to start or stop. It was reported that, the pain was mild to moderate which showed a score of 4 out of 10 on a pain scale. Pain seemed to increase when she used her fingers for anything dexterous, like typing. At that point, the patient could not identify anything to alleviate the pain. At the time of this record the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 52.0
Sex: F
Vaccine: FLUX
Symptoms: Asthenia, Mobility decreased, Musculoskeletal pain, Neck pain, Pain in extremity
Clinical narrative: This is spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 733807), concerns a 52-year-old adult female patient. The patient's medical history was not reported, however the patient's concomitant medications included metformin Hcl, amlodipine besylate, atorvastatin calcium and calcium/ vitamin D. On 01-Dec-2017, the patient was administered with influenza vaccine (dose: unknown, route of administration, trade name, batch number, manufacturer was not reported). On an unspecified date in Dec-2017 (two days after vaccination), the patient's left arm began to hurt. On the third day (on an unspecified date in Dec-2017 after vaccination), pain extended to the shoulder and spread to left side of the neck. The patient lost strength in arm and was not able to lift the arm, due to which she was not able to lift heavy objects. It was reported that, icy patches were applied to alleviate the pain but of no use. The patient visited the physician and was prescribed with BEVODINIX (1 capsule every 12 hours), but pain was not relieved. On an unspecified date, the patient gained strength and was able to lift the arm. However, as the patient tried to lift the arm and past the shoulder, pain in arm persisted. At the time of report, the patient had not yet recovered from the events (asthenia, pain, pain in extremity, neck pain, musculoskeletal pain, mobility decreased).
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 25-Jul-2018 by Seqirus from VAERS (VAERS ID: 733953), concerning a 58-year-old, adult, female patient. The patient had history of hypothyroidism and vitamin D deficiency. The patient was allergic to codeine and sulfa drugs (as reported). The patient was not taking any concomitant medications. On 05-Dec-2017, the patient was administered FLUVIRIN Thiomersal (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 1720901 and expiry date: not reported). On 06-Dec-2017, one day after vaccination, the patient experienced left shoulder pain (injection site pain). It was reported that the event started six weeks prior to this report. At the time of this report, the outcome of the event was unknown. The reporter assessed this case as non-serious.
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Hypoaesthesia, Sensory loss
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 25-Jul-2018 by Seqirus from VAERS (VAERS ID: 733978), concerns a 35-year-old, adult female patient. The patient had no medical history and current illness. The patient was allergic to penicillin. The patient did not receive any concomitant medication. On 17-Oct-2017, the patient was administered FLUVIRIN Thiomersal (dose: 0.5 ml, frequency: 1, route of administration: intramuscular, anatomical location: left arm, batch number: 1720701 and expiry date: not reported). On 20-Oct-2017, 3 days after vaccination, the patient experienced strange numb feeling in her right foot as if she wore a tight sock even after removing sock and shoe. It was reported that, the patient could not feel light stimulation on foot within a week, the sensation had spread to halfway up her lower leg. The sensation lasted around 4 weeks and then diminished. On an unspecified date in 2017, the patient had recovered from the event. The reporter assessed the case as non-serious. Update 24-Aug-2018: Non-significant case correction performed with IRD 25-Jul-2018: Causality statement in case comment was corrected.
Age: 38.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Dizziness, Dysphagia, Electrocardiogram, Palpitations
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 25-Jul-2018 by Seqirus from VAERS (VAERS ID: 733984), concerns a 38-year-old, adult, female patient. It was reported that, patient had no known contraindications to the flu vaccine. On 11-Jan-2018, the patient was administered FLUVIRIN Thiomersal [dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 1721401 and expiry date: not reported]. On the same day, 05 minutes after vaccination, the patient complained of dizziness, heart palpitations, chest tightness, trouble in swallowing and little shortness of breath. Patient's doctor was notified and the doctor prescribed Diphenhydramine (25 mg, intramuscular) and Aspirin 02 tablets (81 mg, PO). The patient's electrocardiogram (EKG) and blood pressure (BP) were recorded (results not reported). The emergency medical services [EMS] arrived when they were contacted. It was reported that, patient was alert and responsive and was taken by the paramedics. The patient had made an office visit. At the time of this report, the outcome of the events was not reported. The reporter assessed the case as non-serious.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Limb discomfort
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 25-Jul-2018 by Seqirus from VAERS (VAERS ID: 734119), concerns a 62-year-old, adult female patient. The patient was allergic to penicillin. On 19-Sep-2017, the patient was administered FLUVIRIN [dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 179603P and expiry date: not reported]. On the same day (19-Sep-2017), after vaccination, the patient experienced soreness in the muscle where the vaccine was given which persisted [reported as still sore]. The patient experienced soreness in the arm whenever she made a fist or laid on that arm. On an unspecified date, the patient consulted the physician who told that the symptoms would eventually go away. It was reported that, the patient tried applying heat to the painful area, but it did not help. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Hypoaesthesia, Paraesthesia, Peripheral coldness
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 25-Jul-2018 by Seqirus from VAERS (VAERS ID: 734513), concerning a 61-year-old, adult, female patient. The patient's current conditions included high blood pressure (reported as BP), thyroid condition (unspecified) and gastroesophageal reflux disease (GERD) (reported as medical history) (since an unspecified date). The patient had no known drug allergy (NKDA). The concomitant medications included lisinopril, Levothyroxine, hydrochlorothiazide, Montelukast and Omeprazole. On 16-Jan-2018, the patient was administered FLUVIRIN [dose: 0.5 ml (frequency reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: 179605P and expiry date: not reported]. On the same day, after vaccination, the patient experienced numbness, tingling and cold feeling in her lower extremities. The patient made an emergency room and office visit. At the time of the report, the patient had not recovered from the events. The reporter assessed this case as non-serious.
Age: 0.92
Sex: M
Vaccine: FLUX
Symptoms: Cough, Irritability, Respiratory tract congestion, Rhinorrhoea
Clinical narrative: This spontaneous case, reported from other health professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 734157), concerns a 11-Months-old, male infant patient. The patient's current condition included stomach virus (since an unspecified date in Jan-2018) (one week prior as reported). The concomitant medication included probiotics for an unknown indication in a baby formula (as reported). On 15-Jan-2018, the patient was administered with influenza vaccine (dose, route of administration, anatomical location, batch number and expiry date: not reported). On the same day (15-Jan-2018), hours after vaccination, the patient was very fussy and experienced a runny nose. On an unspecified date in Jan-2018 (on third day as reported), the patient had been irritable, very congested and developing cough. At the time of this report, the outcome of the events (runny nose, respiratory tract congestion, irritable and cough) was unknown. The reporter assessed the case as non-serious.
Age: 83.0
Sex: F
Vaccine: FLUX
Symptoms: Arthralgia, Asthenia, Blood test, Borrelia test, Dyspnoea
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 734190, concerns an 83-year-old elderly female patient. The patient's historical condition included osteoarthritis (unspecified date). The patient's current illness included cholesterol (since an unspecified date). The patient had been allergic to dairy, soy sauce, strawberries and Sulpha drugs. The patient's concomitant medications included ARMOUR Thyroid and Statin. On 14-Nov-2017, the patient was administered with INN Flu Vaccine Seasonal (dose, route of administration, anatomical location, batch number, expiry date, manufacturer and trade name: not reported). On 15-Nov-2017, after one day of vaccination, the patient experienced muscle and joint pain in legs which moved to shoulders and arms, swelling of legs, hands and dyspnoea. It was worst on left side of body. The muscle, joint pain and mobility had debilitated. The patient also experienced difficulty in walking and got out of chair with the help of arms, and loss of hand strength. On 08-Jan-2018, the patient received corticosteroid shot in left arm, which helped her for one or half week. The patient went to the physician office and blood investigations for rheumatoid arthritis, lyme disease, lupus and arthralgia performed for which results were not reported. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious.
Age: 83.0
Sex: F
Vaccine: FLUX
Symptoms: Dysstasia, Gait disturbance, Grip strength decreased, Musculoskeletal pain, Myalgia
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 734190, concerns an 83-year-old elderly female patient. The patient's historical condition included osteoarthritis (unspecified date). The patient's current illness included cholesterol (since an unspecified date). The patient had been allergic to dairy, soy sauce, strawberries and Sulpha drugs. The patient's concomitant medications included ARMOUR Thyroid and Statin. On 14-Nov-2017, the patient was administered with INN Flu Vaccine Seasonal (dose, route of administration, anatomical location, batch number, expiry date, manufacturer and trade name: not reported). On 15-Nov-2017, after one day of vaccination, the patient experienced muscle and joint pain in legs which moved to shoulders and arms, swelling of legs, hands and dyspnoea. It was worst on left side of body. The muscle, joint pain and mobility had debilitated. The patient also experienced difficulty in walking and got out of chair with the help of arms, and loss of hand strength. On 08-Jan-2018, the patient received corticosteroid shot in left arm, which helped her for one or half week. The patient went to the physician office and blood investigations for rheumatoid arthritis, lyme disease, lupus and arthralgia performed for which results were not reported. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious.
Age: 83.0
Sex: F
Vaccine: FLUX
Symptoms: Pain in extremity, Peripheral swelling, Rheumatoid factor
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 734190, concerns an 83-year-old elderly female patient. The patient's historical condition included osteoarthritis (unspecified date). The patient's current illness included cholesterol (since an unspecified date). The patient had been allergic to dairy, soy sauce, strawberries and Sulpha drugs. The patient's concomitant medications included ARMOUR Thyroid and Statin. On 14-Nov-2017, the patient was administered with INN Flu Vaccine Seasonal (dose, route of administration, anatomical location, batch number, expiry date, manufacturer and trade name: not reported). On 15-Nov-2017, after one day of vaccination, the patient experienced muscle and joint pain in legs which moved to shoulders and arms, swelling of legs, hands and dyspnoea. It was worst on left side of body. The muscle, joint pain and mobility had debilitated. The patient also experienced difficulty in walking and got out of chair with the help of arms, and loss of hand strength. On 08-Jan-2018, the patient received corticosteroid shot in left arm, which helped her for one or half week. The patient went to the physician office and blood investigations for rheumatoid arthritis, lyme disease, lupus and arthralgia performed for which results were not reported. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious.